Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning
Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Jingtao Qiu(Shenzhen Genoimmune Medical Institute), Wei‐Ren Liu(Chung Yuan Christian University), Wei-An Hu(Shenzhen Genoimmune Medical Institute), Jian Zhou(Shenzhen University Health Science Center), Chenyang Tao(Ministry of Education of the People's Republic of China), Hao Zou(Tsinghua University), Xiaoyu Li(Mudanjiang Normal University), Jia Fan(Nanjing Tech University), Kun Qian(Kyushu University), Yucheng Guo(Shenzhen Genoimmune Medical Institute), Zheng Tang(Ministry of Education of the People's Republic of China), Zhi-Xun Wang(Sun Yat-sen University), Meng‐Xin Tian(Sun Yat-sen University), Yingyong Hou(Sun Yat-sen University)
Cited by 23
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828